Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS),

Reena Mahajan1, Jian Xing, Stephen J Liu

  • 1Centers for Disease Control and Prevention, Atlanta, Georgia.

Insights

Hepatitis C virus (HCV) infection is underdocumented on death certificates, with actual mortality rates significantly higher than recorded. Many HCV deaths are misattributed, masking the true impact of the virus.

Area of Science:

  • Hepatology
  • Public Health
  • Epidemiology

Background:

  • Increasing deaths among Hepatitis C Virus (HCV)-infected individuals in the US.
  • Lack of clear understanding of actual mortality rates and causes of death in HCV patients.

Purpose of the Study:

  • To compare mortality data of HCV-infected patients with national death certificate data.
  • To elucidate the true mortality rates and causes of death in HCV-infected individuals.

Main Methods:

  • Observational cohort study (Chronic Hepatitis Cohort Study - CHeCS) of HCV patients.
  • Comparison of CHeCS mortality data with US multiple cause of death (MCOD) data (2006-2010).
  • Analysis of premortem diagnoses, liver biopsies, and FIB-4 scores.

Main Results:

  • HCV patients died younger (mean age 59) than the general population.
  • Liver disease mortality rate in HCV patients was 12 times higher than the general population.
  • HCV was listed on death certificates for only 19% of decedents, despite evidence of chronic liver disease in most.

Conclusions:

  • HCV infection is significantly underdocumented on US death certificates.
  • Estimated actual number of HCV deaths in 2010 may be five times higher than recorded.
  • A majority of HCV-infected individuals who died had premortem indications of chronic liver disease.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
884
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42